Approval for the exponent self-expanding carotid stent system with over-the-wire or rapid-exchange delivery system.  The device is indicated for use, in conjunction with a medtronic vascular embolic protection system, for improving carotid luminal diameter in patients at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: 1) patients with neurological symptoms and >=50% stenosis of the common or internal carotid artery by either ultrasound or angiogram, or patients without neurological symptoms and >=80% stenosis of the common or internal carotid artery by either ultrasound or angiogram; and 2) patients having a vessel with reference diameters between 4.5 mm and 9.5 mm at the target lesion.